2160 Stock Overview
A medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People’s Republic of China and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 5/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for 2160 from our risk checks.
MicroPort CardioFlow Medtech Corporation Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | HK$0.65 |
52 Week High | HK$1.97 |
52 Week Low | HK$0.60 |
Beta | 0.39 |
11 Month Change | -13.33% |
3 Month Change | -35.00% |
1 Year Change | -65.24% |
33 Year Change | -91.88% |
5 Year Change | n/a |
Change since IPO | -96.55% |
Recent News & Updates
Are Investors Undervaluing MicroPort CardioFlow Medtech Corporation (HKG:2160) By 43%?
Aug 07Some MicroPort CardioFlow Medtech Corporation (HKG:2160) Shareholders Look For Exit As Shares Take 26% Pounding
Jun 19MicroPort CardioFlow Medtech (HKG:2160) Is In A Good Position To Deliver On Growth Plans
May 29MicroPort CardioFlow Medtech Corporation (HKG:2160) Shares May Have Slumped 29% But Getting In Cheap Is Still Unlikely
Apr 05Recent updates
Are Investors Undervaluing MicroPort CardioFlow Medtech Corporation (HKG:2160) By 43%?
Aug 07Some MicroPort CardioFlow Medtech Corporation (HKG:2160) Shareholders Look For Exit As Shares Take 26% Pounding
Jun 19MicroPort CardioFlow Medtech (HKG:2160) Is In A Good Position To Deliver On Growth Plans
May 29MicroPort CardioFlow Medtech Corporation (HKG:2160) Shares May Have Slumped 29% But Getting In Cheap Is Still Unlikely
Apr 05We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth
Feb 23An Intrinsic Calculation For MicroPort CardioFlow Medtech Corporation (HKG:2160) Suggests It's 37% Undervalued
Jan 18Companies Like MicroPort CardioFlow Medtech (HKG:2160) Are In A Position To Invest In Growth
Oct 04Not Many Are Piling Into MicroPort CardioFlow Medtech Corporation (HKG:2160) Stock Yet As It Plummets 27%
May 31We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth
May 23The MicroPort CardioFlow Medtech Corporation (HKG:2160) Analysts Have Been Trimming Their Sales Forecasts
Apr 06MicroPort CardioFlow Medtech (HKG:2160) Is In A Good Position To Deliver On Growth Plans
Feb 08We Think MicroPort CardioFlow Medtech (HKG:2160) Can Afford To Drive Business Growth
Oct 18We're Not Very Worried About MicroPort CardioFlow Medtech's (HKG:2160) Cash Burn Rate
Jun 30Analysts Just Made A Major Revision To Their MicroPort CardioFlow Medtech Corporation (HKG:2160) Revenue Forecasts
Apr 04MicroPort CardioFlow Medtech Corporation (HKG:2160) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
Apr 03An Intrinsic Calculation For MicroPort CardioFlow Medtech Corporation (HKG:2160) Suggests It's 49% Undervalued
Jan 21Are Investors Undervaluing MicroPort CardioFlow Medtech Corporation (HKG:2160) By 24%?
Sep 05We're Not Worried About MicroPort CardioFlow Medtech's (HKG:2160) Cash Burn
Jun 07Market Sentiment Around Loss-Making MicroPort CardioFlow Medtech Corporation (HKG:2160)
May 03Shareholder Returns
2160 | HK Medical Equipment | HK Market | |
---|---|---|---|
7D | 6.6% | 4.4% | 1.1% |
1Y | -65.2% | -44.0% | 2.7% |
Return vs Industry: 2160 underperformed the Hong Kong Medical Equipment industry which returned -44% over the past year.
Return vs Market: 2160 underperformed the Hong Kong Market which returned 3% over the past year.
Price Volatility
2160 volatility | |
---|---|
2160 Average Weekly Movement | 6.8% |
Medical Equipment Industry Average Movement | 6.8% |
Market Average Movement | 6.3% |
10% most volatile stocks in HK Market | 13.1% |
10% least volatile stocks in HK Market | 3.3% |
Stable Share Price: 2160's share price has been volatile over the past 3 months.
Volatility Over Time: 2160's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2010 | 592 | Jeffrey R Lindstrom | www.cardioflowmedtech.com |
MicroPort CardioFlow Medtech Corporation, a medical device company, engages in the research, development, and commercialization of transcatheter and surgical solutions for structural heart diseases in the People’s Republic of China and internationally. It offers Vitaflow Aortic Valve System, Alwide Balloon Catheter, and Alpass Introducer Set, Angelguide tip-preshaped super sti¬ff guidewire, mitral, tricuspid, and surgical valves, as well as procedural accessories. The company also provides technical consultation and technical services for medical devices clinical trial.
MicroPort CardioFlow Medtech Corporation Fundamentals Summary
2160 fundamental statistics | |
---|---|
Market cap | HK$1.57b |
Earnings (TTM) | -HK$383.39m |
Revenue (TTM) | HK$421.13m |
3.7x
P/S Ratio-4.1x
P/E RatioIs 2160 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
2160 income statement (TTM) | |
---|---|
Revenue | CN¥382.91m |
Cost of Revenue | CN¥111.38m |
Gross Profit | CN¥271.53m |
Other Expenses | CN¥620.13m |
Earnings | -CN¥348.59m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.14 |
Gross Margin | 70.91% |
Net Profit Margin | -91.04% |
Debt/Equity Ratio | 1.2% |
How did 2160 perform over the long term?
See historical performance and comparison